MedTrace Logo

Colorectal Cancer Screening Intervention Study

NCT06424197 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 799

Last updated 2025-08-08

No results posted yet for this study

Summary

Colorectal cancer (CRC) is one of the leading causes of cancer mortality in the United States, and African Americans (AfAms) still fare worse in CRC incidence and mortality compared to European Americans (EuAms). We propose to examine whether combining both fear-reduction and racially-targeted norm-based messages will increase at-home stool-based CRC screening receptivity and uptake for all African American regardless of level of racial identity. Given low return rates of at-home screening kits, we will also explore whether making an explicit commitment to return screening kits is associated with increased kit returns.

Conditions

Interventions

OTHER

Racial group-targeted messages

Colorectal cancer screening messages targeted towards participants racial group.

OTHER

Explicit Commitment

Indicate explicit commitment to return at home screening kit.

Sponsors & Collaborators

  • National Institutes of Health (NIH)

    collaborator NIH

  • National Institute on Minority Health and Health Disparities (NIMHD)

    collaborator NIH

  • Oakland University

    lead OTHER

Principal Investigators

  • Mark Manning, PhD · Oakland University

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
SINGLE
Model
FACTORIAL

Eligibility

Min Age
45 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-03-01
Primary Completion
2024-04-23
Completion
2024-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06424197 on ClinicalTrials.gov